Blox Labs Inc. (“BLOX” or “the Company”) (CSE:BLOX) (Frankfurt:BR1B) and AgraFlora Organics International Inc. (“AgraFlora”) (CSE:AGRA) (Frankfurt:PU31) (OTCPK:PUFXF), wish to announce that they have executed a letter of intent (“LOI”) to negotiate in good faith a definitive agreement whereby AgraFlora Organics International Inc. (“AGRA) and BLOX intend to enter into a commercial services arrangement (“CSA”). AGRA is a diversified corporation focused on the international cannabis industry that has expertise in all facets of large-scale cultivation and propagation operations, a comprehensive genetics portfolio, access to industry experts, and is developing one of the world’s largest propagation and cultivation facilities (2.2 Million sq. ft.) in Delta, BC. Pursuant to the CSA, AGRA will be retained to help BLOX build a best-in-class team of professionals from the cannabis, agriculture and pharmaceutical sectors to manage and operate its planned hemp business. As consideration for AGRA entering into the CSA, BLOX will issue 20,000,000 common shares at an agreed price of $0.05 per share, subject to completion of the transaction between BLOX and Best Cannabis Products Inc. (“BCP”).

BLOX Labs CEO, Jeff Zanini commented, “the ability to leverage operational and technical expertise from a scaling company such as Agra Flora Organics is an instrumental step in the execution of our future business model”.


The letter of intent between BLOX and AGRA that was previously announced on February 20, 2019 has expired in accordance with the terms of the agreement.

There can be no assurance that the transaction will be completed as proposed or at all. BLOX will provide further disclosure by way of press releases and updates as such additional information becomes available.

About Blox Labs Inc.

On February 28, 2019, Blox announced it had entered into a definitive agreement to acquire all the issued and outstanding securities of BCP in exchange for approximately 234,800,000 common shares of Blox which would result in a reverse takeover and a change of business for Blox. BCP is a Canadian company headquartered in Toronto, Ontario that owns a 50 acre parcel of land, inclusive of a 180,000 sq. ft. state-of-the-art greenhouse, in Leamington, Ontario – a preeminent locale for hemp and cannabis cultivation in Canada. For more information please visit: www.bloxlabs.ca.

About Agraflora Organics International Inc.

Agraflora is a growth-oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, Ont., and is a joint venture partner in Propagation Service Canada and its large-scale, 2.2-million-square-foot greenhouse complex in Delta, B.C. The company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry.

For additional information:

Blox Labs Inc.

Jeff Zanini

President

Blox Labs Inc.
E: ir@bloxlabs.ca

T: 416-262-0871

AgraFlora Organics International Inc.

Tim McNulty
E: ir@agraflora.com
T: (800) 783-6056

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

Click here to connect with Blox Labs Inc. (CSE:BLOX) (Frankfurt:BR1B) for an Investor Presentation.

Source: www.thenewswire.com

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less